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TREM2-mediated early microglial response limits
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T riggering receptor expressed on myeloid cells 2 (TREM2) is a microglial receptor that recognizes changes in the lipid microenvironment, which may occur during amyloid β (Aβ) accumulation and neuronal degeneration in Alzheimer’s disease (AD).
Rare TREM2 variants that affect TREM2 function lead to an increased risk of developing AD. In murine models of AD, TREM2
deficiency prevents microglial clustering around Aβ deposits. However, the origin of myeloid cells surrounding amyloid and the
impact of TREM2 on Aβ accumulation are a matter of debate. Using parabiosis, we found that amyloid-associated myeloid cells
derive from brain-resident microglia rather than from recruitment of peripheral blood monocytes. To determine the impact of
TREM2 deficiency on Aβ accumulation, we examined Aβ plaques in the 5XFAD model of AD at the onset of Aβ-related pathology. At this early time point, Aβ accumulation was similar in TREM2-deficient and -sufficient 5XFAD mice. However, in
the absence of TREM2, Aβ plaques were not fully enclosed by microglia; they were more diffuse, less dense, and were associated with significantly greater neuritic damage. Thus, TREM2 protects from AD by enabling microglia to surround and alter Aβ
plaque structure, thereby limiting neuritic damage.
Alzheimer's disease (AD) is the most common form of
late-onset dementia. Key pathological features of AD consist of the deposition of amyloid-β peptide (Aβ) and hyperphosphorylated tau aggregates that, together, are linked
with synapse loss and neuronal cell death, as well as activation of microglia and astrocytes (Holtzman et al., 2011).
Rare forms of autosomal dominant inherited AD are caused
by mutations in genes involved in the Aβ processing pathway, such as amyloid precursor protein (APP) and presenilin 1 (PSEN1; Tanzi, 2012). The origin of nonfamilial AD
is less well understood and may depend on a combination
of genetic and nongenetic risk factors (Tanzi, 2012). Recent genome-wide association studies have identified rare
variants of genes that encode immune receptors as risk factors (Guerreiro and Hardy, 2014; Karch and Goate, 2015).
Among these, the arginine 47 histidine (R47H) variant of
triggering receptor expressed on myeloid cells 2 (TREM2)
has been found in several cohorts of patients. TREM2 is a
cell surface receptor of the Ig superfamily that is expressed
in microglia of the central nervous system and in other
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tissue macrophages, and binds phospholipids and other
polyanionic ligands (Paloneva et al., 2002; Daws et al., 2003;
Cannon et al., 2012; Wang et al., 2015). TREM2 transmits
intracellular signals through the associated adaptor DNAX
activation protein of 12 kD (DAP12), which recruits the
protein tyrosine kinase spleen tyrosine kinase. TREM2
signaling promotes survival, proliferation, phagocytosis,
and secretion of cytokines and chemokines (Takahashi et
al., 2005; Otero et al., 2009; Wang et al., 2015). TREM2induced signals also augment activation of integrins, thereby
facilitating adhesion and remodeling of the actin cytoskeleton (Takahashi et al., 2005).
We and others have recently examined the impact of
TREM2 deficiency on the microglial response to Aβ deposition in mouse models of AD, including APPPS1-21 and
5XFAD mice (Ulrich et al., 2014; Jay et al., 2015; Wang et
al., 2015). All studies showed that TREM2 deficiency affects clustering of microglia around the plaques. However,
whether Aβ-reactive microgliosis involves resident microglia (Wang et al., 2015) or myeloid cells derived from peripheral blood monocytes (Jay et al., 2015) is still up for
debate. Additionally, the analysis of Aβ accumulation in
different mouse models of AD yielded inconsistent results
© 2016 Wang et al. This article is distributed under the terms of an Attribution–Noncommercial–Share
Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org
/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–
Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
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RESULTS AND DISCUSSION
Aβ-reactive myeloid cells derive from
brain-resident microglia
It has been proposed that the TREM2-dependent microglial response to Aβ plaques in APPPS1-21 mice relies on
the recruitment of blood monocytes (Jay et al., 2015). We
first determined whether blood monocytes in 5XFAD
mice express TREM2 and hence might respond to putative TREM2 ligands present in peripheral blood during
Aβ accumulation. Staining of monocytes from 5XFAD
and wild-type mice with anti-TREM2 revealed no detectable expression of TREM2 (Fig. 1 A). However, it
remained possible that monocytes up-regulate TREM2
upon infiltrating the brain and, therefore, TREM2 would
be required for clustering of infiltrating monocyte around
Aβ plaques. To definitively test for contribution of blood
668

monocytes to the microglial pool in 5XFAD mice, we
performed parabiosis experiments in which the blood
circulation of CD45.2+ 5XFAD mice was joined with
that of age-matched congenic CD45.1+ B6 mice (Fig. 1,
B–E). Parabiosis was performed in 4-mo-old mice or in
8-mo-old mice. After 4 weeks, tissues were analyzed. Total
blood leukocytes and lung alveolar macrophages showed a
marked degree of exchange (Fig. 1, B and C). In contrast,
nearly all microglia in 5XFAD and B6 mice maintained
expression of the original CD45.2 or CD45.1 marker, respectively, consistent with minimal monocyte infiltration
(Fig. 1, B–E). Upon expanding this analysis to APPPS1-21
mice we found results consistent with a lack of infiltration
of CD45.1+ cells into the brain of CD45.2+ APPPS1-21
mice (Fig. 1, F and G). Thus, the contribution of peripheral monocytes to the microglial pool in both 5XFAD and
APPPS1-21 models of AD is negligible.
TREM2 deficiency affects plaque-associated
microglial proliferation
We previously observed an impaired microglial response to
Aβ in 8-mo-old Trem2−/− 5XFAD mice (Wang et al., 2015).
Defective microglial clustering around plaques was also detected at earlier time points in 3- or 4-mo-old Trem2−/−
APPPS1-21 mice (Ulrich et al., 2014; Jay et al., 2015).To test
whether Trem2−/− 5XFAD mice also had an early microglial
defect, we compared the total number of microglia in 4- and
8-mo-old 5XFAD and Trem2−/− 5XFAD mice. Microglial
numbers were similar in 4-mo-old 5XFAD and Trem2−/−
5XFAD mice. In contrast, at 8 mo of age, 5XFAD mice
had a clear increase in total microglia, whereas age-matched
Trem2−/− 5XFAD had fewer microglia (Fig. 2 A). We next
assessed the number of plaque-associated microglia in 4-moold 5XFAD, Trem2+/− 5XFAD, and Trem2−/− 5XFAD mice.
5XFAD mice had significantly more microglial clustering
around plaques than did Trem2+/− and Trem2−/− 5XFAD
mice (Fig. 2, B and C). Thus, an impairment of microglial
response to Aβ deposits was detectable even at 4 mo of age
in Trem2−/− 5XFAD mice.
Given that brain-resident microglia are capable of
self-renewal and expansion (Gomez Perdiguero et al., 2013;
Greter and Merad, 2013; Prinz and Priller, 2014), we next
sought to determine if microglia associated with plaques
resulted from the proliferation of resident microglia. We
analyzed nuclear localization of Ki-67, a well-characterized
proliferation marker, in microglia from 4-mo-old 5XFAD
and Trem2−/− 5XFAD mice in relation to their proximity
to a plaque (Fig. 2, D–G). In 5XFAD mice, the majority of Ki-67+ microglia detected were in close proximity
to Aβ plaques (mean distance = 21.1 µm; Fig. 2, D and
E). In contrast, plaque-associated Ki-67+ microglia were
nearly undetectable in Trem2−/− 5XFAD mice (Fig. 2 F).
Additionally, we observed that Ki-67+ microglia in 5XFAD
mice were preferentially located near plaques with a greater
volume (Fig. 2 G). As more proliferating microglia were
TREM2-mediated microglial response in AD | Wang et al.
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(Tanzi, 2015). In 8-mo-old 5XFAD mice, TREM2 deficiency resulted in increased hippocampal Aβ accumulation,
consistent with a protective function of TREM2 (Wang et
al., 2015). In 4-mo-old APPPS1-21 mice lacking TREM2,
however, hippocampal Aβ accumulation was paradoxically
reduced despite the myeloid cell defect, a finding that was
interpreted to indicate that TREM2 deficiency protects
against AD pathogenesis (Jay et al., 2015).
In this study, we determined whether the Aβ-reactive
myeloid cells are derived from resident microglia or from
infiltrating monocytes in parabiosis experiments. Using
this approach, we observed no infiltration of monocytes
around Aβ plaques in either 5XFAD or APPPS1-21 mice.
Moreover, staining of brain sections for the proliferation
marker Ki67 revealed that TREM2 is necessary for local
proliferation of microglia around the plaques. To explain
the conflicting results regarding the impact of TREM2
deficiency on Aβ accumulation, we hypothesized that
whereas TREM2 deficiency results in early impairment
of the microglial response to Aβ deposits in all AD models, changes in Aβ burden develop more slowly; therefore,
the discrepancies in Aβ accumulation may be a result of
the varied timing of the analyses—8 mo in 5XFAD mice
(Wang et al., 2015) and 3–4 mo in APPPS1-21 mice (Ulrich et al., 2014; Jay et al., 2015). To test this, we examined microgliosis and Aβ deposition at early time points (4
mo) in TREM2-deficient and -sufficient 5XFAD mice. We
found that Aβ deposition was quantitatively similar in the
presence and absence of TREM2. However, TREM2 did
affect microglial clustering and the structure of Aβ plaques
at this early time point; in 5XFAD mice lacking TREM2,
Aβ plaques appeared more diffuse, had altered Aβ subspecies composition, and were associated with increased
neuritic dystrophy compared with those in TREM2-sufficient 5XFAD mice. Collectively, our data demonstrate that
TREM2 is required for the early expansion of microglia
around Aβ plaques that limits plaque diffusion as well as
amyloid-related neuronal damage.

observed near larger plaques in 5XFAD mice, we sought
to determine if there was a correlation between the size of
a plaque and the number of microglia associated with it.
We found that, in 5XFAD mice, the number of microglia
associated with a given plaque was positively correlated
to the size of the plaque (Fig. 2 H). This correlation was
JEM Vol. 213, No. 5

not as strong in Trem2+/− 5XFAD and not apparent in
Trem2−/− 5XFAD (Fig. 2 H).
Finally, as microglia are phagocytic and have been
demonstrated to engulf pieces of plaques, we wished to
examine the number of microglia which had internalized portions of plaques in 5XFAD and Trem2−/− 5XFAD
669
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Figure 1. Lack of monocyte contribution to amyloid-associated microglia.
(A) Surface expression of TREM2 among Ly6C+
CD11b+CD115+ blood monocytes in WT and
5XFAD mice. Trem2−/− mice were used as
negative controls. (B–E) Parabiosis was performed by joining blood circulation of 4- or
8-mo-old 5XFAD with age matched B6.CD45.1
congenic mice for 4 wk. (B) CD45+ blood leukocytes, CD11c+SiglecF+ lung alveolar macrophages, and brain CD11b+F4/80+ microglia
from parabionts were analyzed by flow cytometry. (C) Frequencies of CD45.1+ and CD45.2+
cells were compared in parabiotic partners.
(D and E) Representative images of brain sections of an 8-mo-old 5XFAD parabiont stained
with X-34 (red) for Aβ plaques and Iba-1
(white) for microglia. Contribution of hostand donor-derived microglia was examined
using antibodies specific for CD45.2 (green;
D) and CD45.1 (green; E). Nuclei were visualized with To-pro3 (blue). Bar, 100 µm (F and
G) Parabiosis was performed using APPPS1-21
mice and age-matched B6.CD45.1 congenic
mice for 9 wk. Parabionts were analyzed as
described above. Data represent a total of
five to seven mice per group in A–E and four
mice per group in F and G.

mice by measuring uptake of methoxy-X04, which binds
to fibrillar Aβ (Heneka et al., 2013). Microglia in Trem2−/−
5XFAD mice incorporated less methoxy-X04 than microglia from 5XFAD mice (Fig. 2, I and J), corroborating
that TREM2 deficiency impairs productive interactions
670

between microglia and plaques. Collectively, these data
indicate that TREM2-dependent accrual of resident microglia is a process that initiates early in Aβ deposition and
depends at least in part on local proliferation of microglia
around growing Aβ plaques.
TREM2-mediated microglial response in AD | Wang et al.
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Figure 2. Impaired microglial response to Aβ deposits in Trem2−/− 5XFAD mice is apparent by 4 mo. (A) Total numbers of microglia in the cortices
and hippocampi of 5XFAD and Trem2−/− 5XFAD mice at 4 and 8 mo of age. (B and C) Microglial response to Aβ plaques in 4-mo-ol 5XFAD, Trem2+/− 5XFAD,
and Trem2−/−5XFAD mice. (B) Representative images show matching cortical regions stained with X-34 (red) for amyloid plaques and Iba-1 (white) for microglia. Nuclei were visualized with To-pro3 (blue). (C) Numbers of microglia within 15 or 30 µm of Aβ plaques. (D–F) Microglia proliferation in 5XFAD and
Trem2−/− 5XFAD mice was assessed by determining nuclear localization of Ki-67. (D) Representative sectional view of a confocal image shows expression of
Ki-67 (green), microglia (Iba-1; white), and nuclei (blue). The proximity of Ki-67+ microglia to Aβ plaques (X-34, red), in cortices of 5XFAD mice is visualized.
(E) Proximity of Ki-67+ microglia to the nearest plaque in cortices of 5XFAD. Unfilled circles (*) represent outliers as determined by q-test. (F) Frequencies of
Ki-67+ microglia per HPF in 5XFAD and Trem2−/−5XFAD mice. (G) The volume of all observed Aβ plaques and Aβ plaques with Ki-67+ in close proximity were
compared. (H) The log10-transformed volume of plaques was plotted against the number of microglia within 15 µm. Numbers represent slope ±95% confidence interval. (I and J) 5XFAD and Trem2−/− 5XFAD mice were injected with methoxy-X04 and the percentage of microglia with internalized methoxy-X04
(indicative of fibrillar Aβ) was determined by flow cytometry. (I) Representative plots show methoxy-x04 positivity of CD11b+CD45lo cells. APP transgene
negative (APP–) littermates were used as negative controls. (J) The frequency of methoxy-X04+ microglia was quantified. Bars: (B) 100 µm; (D) 20 µm. Error
bar represents mean ± SEM. *, P < 0.05; ***, P < 0.001; ****, P < 0.0001, Mann-Whitney (A, F, and J) and q-test (E). Data represent a total of five to seven mice
per group (A–F). For confocal images, a total of four random HPF were analyzed per mouse.

TREM2 expression is important in limiting neuronal toxicity
during the early stages of Aβ deposition
Because large, swollen, dystrophic axons and dendrites
(neurites) are associated with Aβ plaques in AD and in
mouse models with Aβ deposition (Masliah et al., 1996;
Brendza et al., 2003), we examined whether altered plaque
morphology and composition was also associated with inJEM Vol. 213, No. 5

creased neuronal damage. We stained sections for the N
terminus (NT) of APP (NT-APP), which accumulates in
dystrophic neurites, and measured NT-APP+ neuronal
processes within 30 µm of Aβ plaques. We found that the
number of dystrophic neurites was significantly increased
in Trem2−/− 5XFAD mice compared with 5XFAD mice
(Fig. 4, A–C). We also stained sections for hyperphosphorylated tau and found an increase in the number and
volume of hyperphosphorylated tau punctae in Trem2−/−
5XFAD mice compared with 5XFAD mice (Fig. 4, D–E).
Thus, the altered Aβ plaque shape and density associated
with TREM2 deficiency observed in Fig. 3 were associated with increased toxicity to neural processes. Overall,
these data indicate that TREM2-mediated microglial response is crucial in compacting Aβ plaques and preventing
damage to the adjacent axons and dendrites.
Concluding remarks
A previous study proposed that TREM2 is important for infiltration of blood-derived monocytes into the brain, which
then mediate Aβ plaque-associated reactive microgliosis (Jay
et al., 2015). This study was based on phenotypic characterization of microgliosis with monocytic- and microgliaspecific markers, along with bone marrow grafts, which enable tracking of congenically marked peripheral monocytes
that traffic into the brain. However, phenotypic markers of
migroglia, such as low expression of CD45 and high expression of the P2Y(12) receptor, are altered upon microglial
activation and therefore do not precisely discriminate microglia from monocytes (Butovsky et al., 2014). Moreover,
whole-body irradiation before bone marrow grafts causes
a blood–brain barrier (BBB) leakage, facilitating an influx
of blood monocytes that may obscure the relative contribution of distinct myeloid cell types during Aβ accumulation
(Mildner et al., 2011). As parabiosis models do not rely on
methods that may compromise the BBB, they may be more
reliable than bone marrow grafts for determining the origin
of microglia. Our parabiosis experiments indicate that the
contribution of peripheral blood monocytes to microgliosis
in mouse models of Aβ accumulation with an unperturbed
BBB is undetectable. Moreover, staining of brain section
with Ki67 suggested that Aβ-associated microgliosis depends
at least in part on the proliferation of brain-resident microglia. Consistent with the predominant impact of brain-resident microglia in the response to amyloid, two recent studies
showed that in a transgenic mouse model of Aβ deposition
in which microglia are depleted after intracranial injection
of gangliocyclovir and replaced with infiltrating monocytes,
the infiltrating cells co-localize with Aβ plaques only after a
long period of time and are not efficient at clearing plaques
(Prokop et al., 2015;Varvel et al., 2015).
Recently, microglia around Aβ plaques were shown to
form a physical barrier that prevents outward plaque expansion and leads to compact plaque microregions with low
Aβ1-42 affinity (Condello et al., 2015). Areas not covered by
671
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TREM2 deficiency alters the physical appearance and
composition of Aβ plaques
To determine if TREM2 impacted Aβ deposition at 4 mo
of age, we compared the total insoluble Aβ1-42 and Aβ1-40
from 5XFAD, Trem2+/− 5XFAD, and Trem2−/− 5XFAD
mice in the hippocampus and cortex by ELI
SA. We
found no differences in the total Aβ1-42 or Aβ1-40 present
in any of the genotypes (Fig. 3, A–D). Consistent with
these findings, we did not detect a significant difference in
X-34 staining in the cortices of Trem2−/− 5XFAD mice
(Fig. 3 E). However, TREM2 had a remarkable influence on the structure of Aβ plaques. Fibrillar Aβ plaques
from 5XFAD mice at 4 mo of age were compact with
well-defined, condensed cores and few surrounding diffuse
structures (Fig. 3 F). In contrast, plaques from Trem2−/−
5XFAD mice appeared more loosely packed with smaller
cores and many fiber-like structures extending outwards
(Fig. 3 F). A quantitative morphology index based on the
perimeter versus area of Aβ plaques in multiple brain sections confirmed TREM2-dependent differences in the
morphology of Aβ plaques (Fig. 3 G). Furthermore, computation of pixels within Aβ plaque images demonstrated
that plaque density was also TREM2 dependent (Fig. 3, H
and I). Shape and density differences were also apparent in
8-mo-old mice (Fig. 3, F–I).
We sought to determine whether plaques from 5XFAD
and Trem2−/− 5XFAD mice also differed in the biochemical
profile of the Aβ deposits. It has been previously observed
that Aβ plaques contain several Aβ subspecies resulting from
truncation and/or posttranslational modification of the Aβ1-42
peptides (DeMattos et al., 2012; Kummer and Heneka, 2014),
including Aβp3-42, a truncated form of Aβ with a pyroglutamate modification at position 3 (Harigaya et al., 2000). To
determine if the accumulation of Aβ subspecies was affected
by TREM2 deficiency, we analyzed the insoluble fractions of
Aβ from the brains of 8-mo-old 5XFAD, Trem2+/− 5XFAD,
and Trem2−/− 5XFAD mice by denaturing acid/urea PAGE,
followed by immunoblotting using antibodies against various
epitopes of Aβ (DeMattos et al., 2002). We observed that the
abundance of Aβp3-42 relative to Aβ1-42 was reduced in the hippocampi of Trem2+/− 5XFAD and Trem2−/− 5XFAD mice.
In addition, the relative abundance of other Aβ subspecies,
such as Aβ1-42-1 and Aβ1-42-2, was reduced in a similar fashion in Trem2+/− 5XFAD and Trem2−/− 5XFAD mice (Fig. 3,
J and K). Thus, TREM2 deficiency not only influences the
physical appearance of the plaques, but also alters the Aβ
subspecies composition.

microglia are less compact and contain protofibrillar hotspots
with high Aβ1-42 affinity, which are associated with more severe axonal dystrophy. Our data show that in the absence of
TREM2-mediated microgliosis, Aβ plaques are less dense,
more diffuse, and have some alterations in their biochemical
672

features, exemplified by the reduced abundance of various
Aβ subspecies in 5XFAD mice.Whether microglia influence
the conversion of Aβ1-42 into other Aβ species by enabling
Aβ-modifying enzymes to act more efficiently on aggregated
forms of Aβ remains an open question. More importantly,
TREM2-mediated microglial response in AD | Wang et al.
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Figure 3. TREM2 deficiency alters physical
appearance and biochemical composition
of amyloid plaques. (A–D) Accumulation of
insoluble Aβ1-42 (A and B) and Aβ1-40 (C and D)
in the cortices and hippocampi of 4-mo-old
5XFAD, Trem2+/−5XFAD, and Trem2−/−5XFAD
mice was determined by ELISA. (E) Deposition of fibrillar Aβ in the cortices determined
by X-34 staining. Levels of X-34 signal in the
hippocampi were below the threshold of detection. (F–I) Morphology of fibrillar plaques
in 4-mo-old 5XFAD and Trem2−/−5XFAD
mice. X-34–reactive fibrillar plaques were
visualized using high-resolution confocal
microscopy (F) and converted to heat-map
images based on pixel intensity (H). Physical
appearance of X-34-reactive fibrillar plaques
was further quantified based on morphology
(G) and pixel intensity (I). Diffuse shape and
reduced density were also apparent in 8-moold Trem2−/−5XFAD mice (F and H). (J) Representative urea immunoblots showing the
detection of Aβ1-42, Aβ1-42+1, Aβ1-42-1, Aβ1-42-2,
and Aβp3-42 from insoluble fractions of hippocampi from 5XFAD mice. (K) Quantification
of insoluble Aβ species by urea immunoblots
in the cortices and hippocampi of 5XFAD,
Trem2+/−5XFAD, and Trem2−/−5XFAD mice.
Abundance of Aβ1-42+1, Aβ1-42-1, Aβ1-42-2, and
Aβp3-42 relative to Aβ1-42 is shown. Amount of
Aβ used for standard curves are indicated. Bar,
10 µm. *, P < 0.05; ** P < 0.01; ****, P < 0.0001,
VA
Mann-Whitney (G and I), two-way ANO
(E and K). Data represent a total of 8–14 mice
per group in A–E, eight mice per group in F–I
and five mice per group in K. For confocal images, a total of four random HPF were analyzed
per mouse. Error bar represents mean ± SEM.

MATERIALS AND METHODS
Mice. Trem2−/− mice were previously described (Turnbull et al., 2006). 5XFAD mice (Oakley et al., 2006) were
purchased from The Jackson Laboratory (MMR
RC) and
crossed to Trem2−/− mice to generate Trem2+/−5XFAD and
Trem2−/−5XFAD mice (Wang et al., 2015). Parabiotic mice
were joined by the surgery core in the Hope Center for Neurological Disorders (Washington University, St. Louis, MO). In
brief, the skin along the opposite flanks of parabiotic pairs was
joined under general anesthesia and pairs were housed for the
indicated postoperative time. All animal studies were approved
by the Washington University Animal Studies Committee.

Figure 4. Neuritic dystrophy and the amounts of phospho-tau in
proximity to plaques are markedly increased in the absence of TREM2.
(A–C) Neuritic dystrophy in 5XFAD and Trem2−/−5XFAD mice was visualized
using 22C11 mAb against the APP N terminus (APP-NT). (A) Representative
images show APP-NT+ neurites (green), Aβ plaques (X-34; red), and nuclei
(To-pro3; blue). (B and C) Quantification of total volume and numbers of
APP-NT+ neurites within 30 µm of Aβ plaques. (D–F) Hyperphosphorylated
tau in 5XFAD and Trem2−/−5XFAD mice. Sections were stained with anti–
phospho-tau antibody (AT8; green) and Aβ plaques (red; D). Total volume of
AT8+ neurites (E) and the number of AT8+ spots per HPF (F) were quantified.
Bar, 20 µm. *, P < 0.05; ****, P < 0.0001, by Mann-Whitney. Data represent
a total of four to eight mice per group. For confocal images, a total of four
random HPF were analyzed per mouse. Error bar represents mean ± SEM.

the altered Aβ plaque morphology associated with TREM2
deficiency led to enhanced toxicity potential, as indicated
by the increase in neuritic dystrophy. These results indicate
that TREM2 has a major impact on the early containment
of plaque diffusion by microglia. This impact is appreciable even at 4 mo of age, although the total Aβ present in
TREM2-sufficient and -deficient 5XFAD mice is similar.
We postulate that lack of this function for a long period
of time leads to the increase in hippocampal Aβ1-42 levels
in 8-mo-old TREM2-deficient mice that we previously reported (Wang et al., 2015). Collectively, our studies highlight
the protective role of TREM2 expression in brain-resident
microglia by influencing the structure, biochemical composition, and toxicity of Aβ deposits and provide novel insights
into the mechanisms by which TREM2 acts in the early
stages of AD development.
JEM Vol. 213, No. 5

Confocal imaging and quantification.40-µm floating sections
were stained with Iba-1 (Wako Pure Chemical Industries),
X-34, and Topro-3 for visualization of microglia, plaques, and
nuclei, respectively. Confocal images were collected using a
Nikon A1R+ confocal microscope. 4–5 z-stack images (447
× 447 × 30 µm; 1.25 µm thickness) were acquired per animal
in random cortical regions and hippocampal regions. Images
were then processed with Imaris (Bitplane). Coordinates of
microglia and the location and volume of Aβ plaques were
identified using the Particle and Surface function, respectively,
and imported into Matlab (Mathworks). Number of microglia within a 15- and 30-µm radius were then determined
using an automated script. Dystrophic neurites were identified using 22C11 antibody against the N terminus of APP
(EMD Millipore) followed by Alexa Fluor 555–conjugated
anti–mouse IgG. Proliferating cells were identified using an
anti–Ki-67-biotin (SolA15; eBioscience), followed by Alexa
Fluor 488–conjugated streptavidin (Molecular Probes). Hyperphosphorylated tau was detected with AT8 antibody
(Thermo Fisher Scientific). For plaque morphology analysis,
high-resolution images were collected at 60× magnification
with 1.5× digital zoom. Maximum intensity projection of the
z-stack for each plaque was subsequently used for morphological analysis. To trace the shape of plaques, we applied a
combination of intensity thresholds and edge detection in
Matlab. First, the mean intensity of the brightest 10 pixels in
the image (max intensity) was used to normalize the range.
Pixels with intensity >0.5 times this max intensity formed a
bright mask, and pixels <0.1 times this max formed a background mask. Next, edges were detected using the Laplacian
of Gaussian method and dilated to generate a closed object.
This object was overlaid with the bright mask, with the back673
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Preparation of brain samples.For histological analysis, mice
were anesthetized with ketamine and perfused with ice-cold
PBS. Right-brain hemispheres were fixed in 4% PFA overnight and placed in 30% sucrose before freezing and cutting on
a freezing sliding microtome. Serial 40-µm coronal sections of
the brain were collected from the rostral anterior commissure
to caudal hippocampus as landmarks. For biochemical analysis, cortices, and hippocampi of the left-brain hemispheres
were dissected out and flash frozen in liquid nitrogen.

Denaturing acid/urea polyacrylamide gel electrophoresis
(PAGE) and ELISA.A mouse anti–Aβ33-42 antibody (21F12)
was used for capture and biotinylated mouse anti–Aβ1-5 antibody (3D6) or mouse anti–Aβp3-42 antibody (mE8) was used
for detection of Aβ1-42 or Aβp3-42, respectively (DeMattos et
al., 2012), followed by streptavidin HRP (SouthernBiotech).
All ELISAs were developed using Super Slow ELISA TMB
(Sigma-Aldrich) and absorbance read on a Bio-Tek Epoch
plate reader at 650 nm. The standard curves for each assay
used synthetic human Aβ1-42 or Aβp3-42 peptide (AnaSpec).
Denaturing Acid/Urea PAGE was performed as previously
described (DeMattos et al., 2002). Subsequent standard immunoblotting was used for Aβ identification.

ANOVA with correction for multiple comparisons. Comparison of two groups was performed using a two-tailed
unpaired t test (Mann Whitney). Values were accepted as
significant if P ≤ 0.05.
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